Bonus BioGroup Ltd. (TASE:BONS) announced that it has entered into a purchase agreement with new investor Wize Pharma, Inc. (OTCPK:WIZP) for private placement of 51,282,000 common shares at a price of ILS 0.50 per share for gross proceeds of ILS 25,641,000 on January 9, 2020. The company will receive $500,000 (ILS 1,732,500) as advance on execution of agreement, $3,200,000 (ILS 11,088,000) at the closing of transaction, and $3,700,000 (ILS 12,820,500) at milestone closing. The shares to be issued are subject to lock-up. The closing to transaction will occur on 2nd business day immediately following the satisfaction of all the closing conditions. The transaction is subject to approval of Tel Aviv Stock Exchange.